Anteris Technologies Global Corp. (NASDAQ:AVR) Receives $16.00 Average Target Price from Brokerages

Anteris Technologies Global Corp. (NASDAQ:AVR) has been given a consensus rating of “Moderate Buy” by the five analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $16.00.

A number of research firms recently issued reports on AVR. Barclays increased their price target on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research report on Friday, August 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Wednesday. Finally, Wall Street Zen raised Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th.

Insiders Place Their Bets

In related news, major shareholder L1 Capital Pty Ltd sold 558,633 shares of the firm’s stock in a transaction that occurred on Thursday, July 30th. The shares were sold at an average price of $8.20, for a total value of $4,580,790.60. Following the transaction, the insider owned 6,633,314 shares of the company’s stock, valued at approximately $54,393,174.80. This trade represents a 7.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders sold a total of 3,000,659 shares of company stock valued at $25,174,702 over the last 90 days. 4.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of AVR. Russell Investments Group Ltd. boosted its stake in Anteris Technologies Global by 76.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock worth $29,000 after purchasing an additional 2,841 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Anteris Technologies Global during the 1st quarter valued at $32,000. BNP Paribas Financial Markets raised its stake in shares of Anteris Technologies Global by 83.3% in the third quarter. BNP Paribas Financial Markets now owns 9,469 shares of the company’s stock valued at $43,000 after acquiring an additional 4,302 shares during the period. Bank of America Corp DE raised its position in Anteris Technologies Global by 35.7% in the 3rd quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock worth $48,000 after purchasing an additional 2,798 shares during the period. Finally, Duncan Williams Asset Management LLC bought a new stake in shares of Anteris Technologies Global during the 4th quarter worth approximately $54,000.

Anteris Technologies Global Trading Down 2.6%

Shares of NASDAQ:AVR opened at $8.74 on Friday. The stock’s 50-day moving average price is $9.07 and its 200-day moving average price is $7.60. The stock has a market capitalization of $851.80 million, a P/E ratio of -4.48 and a beta of 1.78. Anteris Technologies Global has a 12-month low of $3.30 and a 12-month high of $11.06.

Anteris Technologies Global (NASDAQ:AVR) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.09). The company had revenue of $1.01 million during the quarter, compared to the consensus estimate of $1.50 million. Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. During the same quarter in the previous year, the firm posted ($0.58) EPS. As a group, research analysts predict that Anteris Technologies Global will post -1.21 EPS for the current year.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.